Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study.

Jesus Manuel Rivera EstebanAlba Jiménez-MasipSergio Muñoz-MartínezSalvador AugustinRafael A GuerreroPablo Gabriel-Medina Roser Ferrer Francisco Rodriguez-FríasElisabet TuruAndrés MarcoJuan M Pericàsnull On Behalf Of The Prisonafld Study Group Collaborators

Published in: Journal of clinical medicine (2023)

Metabolic disorders including MASLD are highly prevalent among inmates. The prevalence of significant fibrosis seems notably higher than that of the general population, underscoring the need for targeted screening programs and therapeutic interventions in the incarcerated population.

Keyphrases

liver fibrosis
risk factors
physical activity
public health
cancer therapy
drug delivery